AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Switglim-M 3mg/1000mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Akumentis Healthcare Ltd

Salt Composition

Glimepiride (3mg) + Metformin (1000mg)

Overview Switglim-M 3mg/1000mg Tablet PR

DiaBetaComb 3mg/1000mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication assists in regulating blood glucose levels. DiaBetaComb 3mg/1000mg tablets should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar or feeling well; abrupt cessation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a quick-acting glucose source like candy or juice. Alcohol increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding women should consult their doctor. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function may be recommended by your physician.

Primary Ingredients of Switglim-M 3mg/1000mg Tablet PR

No information provided. Please provide the text you wish me to rephrase.

Uses of Switglim-M 3mg/1000mg Tablet PR

Managing type 2 diabetes

Major Benefits of Switglim-M 3mg/1000mg Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer Switglim-M 3mg/1000mg Tablet PR with food.

Common Side effects of Switglim-M 3mg/1000mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Switglim-M 3mg/1000mg Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer Switglim-M 3mg/1000mg Tablet PR with a meal.

How Switglim-M 3mg/1000mg Tablet PR works:

Switglim-M 3mg/1000mg tablets are a dual-action antidiabetic formulation containing glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Switglim-M 3mg/1000mg tablets (PR) with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Switglim-M 3mg/1000mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Switglim-M 3mg/1000mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Switglim-M 3mg/1000mg Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. Switglim-M 3mg/1000mg Tablet PR is contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Switglim-M 3mg/1000mg Tablet PR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate liver disease, a low initial dose is typically recommended; however, Switglim-M 3mg/1000mg Tablet PR is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Switglim-M 3mg/1000mg Tablet PR :

Should you forget a Switglim-M 3mg/1000mg PR tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Switglim-M 3mg/1000mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Switglim-M 3mg/1000mg Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions provided. Dispose of any unused medication properly and ensure it remains inaccessible to children, pets, and others.
Switglim-M 3mg/1000mg Tablet PR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Switglim-M 3mg/1000mg Tablet PR and seek immediate medical attention.
Switglim-M 3mg/1000mg tablets are a dual-action treatment for type 2 diabetes mellitus (DM) in adults. Combining glimepiride and metformin, this medication improves blood sugar control when coupled with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 DM.
Switglim-M 3mg/1000mg Tablet PR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Switglim-M 3mg/1000mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Switglim-M 3mg/1000mg Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Switglim-M 3mg/1000mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Switglim-M 3mg/1000mg Tab...
122
MRP 141
13% off